Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia

Current Medical Research and Opinion

Volumn 20, Issue 12, 2004, Pages 1979-1991

  Zammit, Gary K ^a   McNabb, Louis J ^b   Caron, Judy ^c   Amato, David A ^c   Roth, Thomas ^d  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b ST JUDE MEDICAL CENTER   (United States)

^c SUNOVION PHARMACEUTICALS INC   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Chronic insomnia; Eszopiclone; Long term; Non benzodiazepine; Sleep; Sleep initiation and maintenance disorder; Tolerance

Indexed keywords

ESZOPICLONE; PLACEBO;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP PATTERN; SLEEP STAGE; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TASTE DISORDER; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLACEBOS; POLYSOMNOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS; TASTE; TREATMENT OUTCOME;

EID: 13144294025     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/174234304X15174     Document Type: Article

References (41)

1. Roth T. New developments for treating sleep disorders. J Clin Psychiatry 2001;62(Suppl 10):3-4
2. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22(Suppl 2):S347-S353
3. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111
4. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32
5. Rosa RR, Bonnet MH. Reported chronic insomnia is independent of poor sleep as measured by electroencephalography. Psychosom Med 2000;62:474-82
6. Stepanski E, Zorick F, Roehrs T, et al. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 1988;11:54-60
7. Hohagen F, Kappler C, Schramm E, et al. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening - temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994;17:551-4
8. Scharf MB, Roth PB, Dominguez RA, et al. Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia. J Clin Pharmacol 1990;30:461-7
9. Kripke DF, Hauri P, Ancoli-Israel S, et al. Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990;10:32S-43S
10. Rush CR, Griffiths RR. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 1996;16:146-57
11. Scharf MB, Fletcher K, Graham JP. Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiatry 1988;49:134-7
12. Roth T, Hartse KM, Saab PG, et al. The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacology (Berl) 1980;70:231-7
13. Judd LL, Ellinwood E, McAdams LA. Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990;10:56S-67S
14. Johnson LC, Chernik DA, Hauri P. A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions. J Clin Psychopharmacol 1990;10:76S-90S
15. Ware JC, Walsh JK, Scharf MB, et al. Minimal rebound insomnia after treatment with 10-mg zolpidem. Clin Neuropharmacol 1997;20:116-25
16. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharm 1998;13:191-8
17. Hajak G, Cluydts R, Declerck A, et al. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 2002;17:9-17
18. Scharf MB, Roth T, Vogel GW, et al. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994;55:192-9
19. Hedner J, Yaeche R, Emilien G, et al. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry 2000;15:704-12
20. Elie R, Ruther E, Farr I, et al. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic [Zaleplon Clinical Study Group]. J Clin Psychiatry 1999;60:536-44
21. Walsh JK, Vogel GW, Scharf M, et al. A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 2000;1:41-9
22. Davies M, Newell JG, Derry JM, et al. Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors. Mol Pharmacol 2000;58:756-62
23. Doble A. New insights into the mechanism of action of hypnotics. J Psychopharmacol 1999;13:S11-S20
24. Leese P, Maier G, Vaickus L, et al. Esopiclone: pharmacokinetic and pharmacodynamic effects of a novel sedative hypnotic after daytime administration in healthy subjects. Sleep 2002;25:A45
25. Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. J Affect Disord 1990;19:53-61
26. Dockhorn RJ, Dockhorn DW. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial. Clin Neuropharmacol 1996;19:333-40
27. Ponciano E, Freitas F, Camara J, et al. A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. Int Clin Psychopharmacol 1990;5(Suppl 2):69-77
28. Gringras M, Beaumont G, Ankier SI. A comparison of the hypnotic activity of loprazolam, temazepam and placebo in general practice. J Int Med Res 1984;12:10-6
29. Scharf MB, Mayleben DW, Kaffeman M, et al. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 1991;52:77-83
30. Kaynak H, Kaynak D, Gozukirmizi E, et al. The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med 2004;5:15-20
31. Metz A, Shader RI. Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. Int Clin Psychopharmacol 1990;5:191-4
32. Blazer DG, Hays JC, Foley DJ. Sleep complaints in older adults: a racial comparison. J Gerontology: Med Sci 1995;50A:M280-M284
33. Jean-Louis G, Magai CM, Cohen CI, et al. Ethnic differences in self-reported sleep problems in older adults. Sleep 2001;17:703-10
34. National Sleep Foundation. Sleep in America poll. Washington DC: Author; 2002
35. Walsh JK, Fry J, Erwin CW, et al. Efficacy and tolerability of 14-day administration of zaleplon 5 mg and 10 mg for the treatment of primary insomnia. Clin Drug Invest 1998;16:347-54
36. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989;9:161-72
37. Hajak G, Clarenbach P, Fischer W, et al. Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci 1998;248:148-56
38. Hegelbach-Feller DA, Tschopp JM, Christeller S, et al. Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo. Arzneimittelforschung 1988;38:387-92
39. Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 1992;20:150-61
40. Roger M, Attali P, Coquelin JP. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther 1993;15:127-36
41. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-9